Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Fenzian™ Treatment on Symptoms, Pulmonary Function and Albuterol/Salbutamol Use in Patients With Mild to Moderate Persistent Asthma: A Multicenter, Sham-Controlled Clinical Trial

NCT00784758 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00784758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00784758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Fenzian™ Treatment on Symptoms, Pulmonary Function and Albuterol/Salbutamol Use in Patients With Mild to Moderate Persistent Asthma: A Multicenter, Sham-Controlled Clinical Trial
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2009
Completion date
June 30, 2011
Enrollment
81 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma